Walleye Trading LLC Denali Therapeutics Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $4.97 Million - $7.41 Million	226,753 New	226,753 $5.22 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $42,000 - $65,497	-835 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $111,150 - $168,440	-2,066 Reduced 71.22%	835 $48,000
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $107,017 - $271,417	2,901 New	2,901 $243,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.